YERVOY (ipilimumab)

**Product type:** Human Prescription Drug

**Active ingredient:** IPILIMUMAB

**Strength:** 5 mg/mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** E.R. Squibb & Sons, L.L.C.

**Marketing category:** BLA (BLA125377)

**Pharmacologic class:** CTLA-4-directed Antibody Interactions [MoA], CTLA-4-directed Blocking Antibody [EPC], Increased T Lymphocyte Activation [PE]